Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery
Launched by ZAGAZIG UNIVERSITY · Dec 20, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief for patients undergoing hip fracture surgery. The researchers want to compare a technique called the circum-psoas block with another method that combines lumbar and sacral plexus blocks. Both techniques aim to help manage pain after surgery and improve recovery, but there hasn't been a study directly comparing them before. Effective pain management is crucial because it helps patients move around sooner, reduces the risk of complications, and can lead to shorter hospital stays.
To participate in this trial, you need to be an adult scheduled for your first hip fracture surgery within the next few days, have a Body Mass Index (BMI) of 30 or less, and be in generally good health (classed as ASA I-III). However, if you have multiple fractures, certain medical conditions, or a history of chronic pain, you may not be eligible. If you join the trial, you can expect to receive one of the two pain relief methods before your surgery, and the team will monitor your pain levels and recovery closely. This study aims to find the best way to manage pain for patients like you after hip surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient acceptance.
- • BMI ≤ 30 kg/m2
- • ASA I-III.
- • First unilateral surgery for hip fracture including femoral neck, intertrochanteric or subtrochanteric fracture.
- • Patient with planned hip fracture surgery within 24-72 hours under general anesthesia.
- Exclusion Criteria:
- • Multiple trauma, multiple fractures, or pathological fractures
- • Prosthetic fracture or usage of bone-cement fixation in the surgery.
- • Scheduled for bilateral hip fracture surgery.
- • Pre-existing neurological deficit in the lower extremity
- • Contraindication for peripheral nerve block (infection at the site of needle insertion, coagulopathy, allergy to local anesthetics used)
- • History of chronic pain and taking analgesics
- • History of cognitive dysfunction or mental illness
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Alsharqia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials